Literature DB >> 2848046

Calcium uptake evoked by electrical stimulation is enhanced postischemically and precedes delayed neuronal death in CA1 of rat hippocampus: involvement of N-methyl-D-aspartate receptors.

P Andiné1, I Jacobson, H Hagberg.   

Abstract

Extracellular calcium concentration changes in the CA1 of the hippocampus during burst activity were measured during postischemic reflow, and the involvement of N-methyl-D-aspartate (NMDA) receptors was evaluated. In adult Wistar rats global ischemia was induced by four-vessel occlusion for 20 min. After 6 h of postischemic reflow, the animals were halothane-anesthetized and reintubated. A double-barrelled calcium-sensitive microelectrode was advanced through stratum oriens, pyramidale, and radiatum in 50-micron steps. At each step the perforant pathway was stimulated (15 Hz, 30 s), and changes in extracellular calcium concentration were recorded. High-frequency stimulation elicited burst firing and transient decreases in extracellular calcium concentration, which are interpreted as neuronal calcium uptake. In control hippocampus, the extracellular calcium decreases were maximal in the stratum pyramidale. Six to eight hours after ischemia, a threefold enhancement of extracellular calcium decreases was found in the dendritic layers of the CA1. The NMDA-receptor antagonist ketamine (15-30 mg/kg intraperitoneally) reduced these electrically evoked calcium decreases. Seven days after ischemia, there was a 60-90% loss of pyramidal cells in the CA1. In conclusion, the cellular calcium uptake, possibly through NMDA receptors evoked by neuronal activity, is enhanced during early postischemia and precedes delayed neuronal death.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848046     DOI: 10.1038/jcbfm.1988.135

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  12 in total

1.  Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia.

Authors:  T F Freund; G Buzsáki; A Leon; K G Baimbridge; P Somogyi
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

Review 2.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

Review 3.  Postischemic hypothermia. A critical appraisal with implications for clinical treatment.

Authors:  F Colbourne; G Sutherland; D Corbett
Journal:  Mol Neurobiol       Date:  1997-06       Impact factor: 5.590

4.  The nootropic drug vinpocetine inhibits veratridine-induced [Ca2+]i increase in rat hippocampal CA1 pyramidal cells.

Authors:  T Zelles; L Franklin; I Koncz; B Lendvai; G Zsilla
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

5.  Redox modulation of synaptic responses and plasticity in rat CA1 hippocampal neurons.

Authors:  C L Bernard; J C Hirsch; R Khazipov; Y Ben-Ari; H Gozlan
Journal:  Exp Brain Res       Date:  1997-02       Impact factor: 1.972

6.  Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus.

Authors:  R Torp; D Lekieffre; L M Levy; F M Haug; N C Danbolt; B S Meldrum; O P Ottersen
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

Review 7.  Energy metabolism and selective neuronal vulnerability following global cerebral ischemia.

Authors:  N R Sims
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

8.  The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia.

Authors:  R Gill; C Brazell; G N Woodruff; J A Kemp
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

9.  Histochemical study of Ca(2+)-ATPase activity in ischemic CA1 pyramidal neurons in the gerbil hippocampus.

Authors:  K Oguro; M Nakamura; T Masuzawa
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 10.  Global cerebral ischemia: synaptic and cognitive dysfunction.

Authors:  Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.